Islet amyloid inhibitors improve glucose homeostasis in a transgenic mouse model of type 2 diabetes
Increasing evidence points to the cytotoxicity of islet amyloid polypeptide (IAPP) aggregates as a major contributor to the loss of β‐cell mass in type 2 diabetes. Prevention of IAPP formation represents a potential treatment to increase β‐cell survival and function. The IAPP inhibitory peptide, D‐A...
Saved in:
Published in | Diabetes, obesity & metabolism Vol. 17; no. 10; pp. 1003 - 1006 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.10.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Increasing evidence points to the cytotoxicity of islet amyloid polypeptide (IAPP) aggregates as a major contributor to the loss of β‐cell mass in type 2 diabetes. Prevention of IAPP formation represents a potential treatment to increase β‐cell survival and function. The IAPP inhibitory peptide, D‐ANFLVH, has been previously shown to prevent islet amyloid accumulation in cultured human islets. To assess its activity in vivo, D‐ANFLVH was administered by intraperitoneal injection into a human IAPP transgenic mouse model, which replicates type 2 diabetes islet amyloid pathology. The peptide was a potent inhibitor of islet amyloid deposition, resulting in reduced islet cell apoptosis and preservation of β‐cell area leading to improved glucose tolerance. These findings provide support for a key role of islet amyloid in β‐cell survival and validate the application of anti‐amyloid compounds as therapeutic strategies to maintain normal insulin secretion in patients with type 2 diabetes. |
---|---|
Bibliography: | Canadian Institute of Health Research (CIHR) - No. MOP-115056 ark:/67375/WNG-K4HLDTPZ-H Appendix S1. Supplementary methods. istex:DEA4736E875518B646E72B50D8993411F00D3182 ArticleID:DOM12529 SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Correspondence-1 |
ISSN: | 1462-8902 1463-1326 |
DOI: | 10.1111/dom.12529 |